Anileridine (trade name: Leritine) is a synthetic analgesic drug and is a member of the piperidine class of analgesic agents developed by Merck & Co. in the 1950s.[1] It differs from pethidine (meperidine) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increases its analgesic activity.
Anileridine is no longer manufactured in the US or Canada.[2]
Administration [edit]
As tablets or injection.[3]
Pharmacokinetics [edit]
Anileridine usually takes effect within 15 minutes of either oral or intravenous administration, and lasts 2–3 hours.[4] It is mostly metabolized by the liver.
References [edit]
|
|
|
Opioids
See also: Opioids template |
|
Opium & alkaloids thereof
|
|
|
|
Semi-synthetic opium
derivatives
|
|
|
|
Synthetic opioids
|
|
|
|
| Pyrazolones |
|
|
| Cannabinoids |
|
|
| Anilides |
|
|
Non-steroidal
anti-inflammatories
See also: NSAIDs template |
|
Propionic acid class
|
|
|
|
Oxicam class
|
|
|
|
Acetic acid class
|
|
|
|
|
|
|
|
Anthranilic acid
(fenamate) class
|
|
|
|
|
|
|
|
Atypical, adjuvant and potentiators,
metabolic agents and miscellaneous |
|
|
|
|
|
|
|
|
(what is this?) (verify)
